- Home
- AKTX vs INKT Comparison
AKTX vs INKT Comparison
Compare AKTX & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- INKT
- Stock Information
- Founded
- AKTX N/A
- INKT 2017
- Country
- AKTX United States
- INKT United States
- Employees
- AKTX N/A
- INKT N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- INKT Medicinal Chemicals and Botanical Products
- Sector
- AKTX Health Care
- INKT Health Care
- Exchange
- AKTX Nasdaq
- INKT Nasdaq
- Market Cap
- AKTX 34.7M
- INKT 28.5M
- IPO Year
- AKTX N/A
- INKT 2021
- Fundamental
- Price
- AKTX $1.20
- INKT $0.83
- Analyst Decision
- AKTX
- INKT Strong Buy
- Analyst Count
- AKTX 0
- INKT 2
- Target Price
- AKTX N/A
- INKT $6.50
- AVG Volume (30 Days)
- AKTX 71.7K
- INKT 214.1K
- Earning Date
- AKTX 02-15-2025
- INKT 11-14-2024
- Dividend Yield
- AKTX N/A
- INKT N/A
- EPS Growth
- AKTX N/A
- INKT N/A
- EPS
- AKTX N/A
- INKT N/A
- Revenue
- AKTX N/A
- INKT N/A
- Revenue This Year
- AKTX N/A
- INKT N/A
- Revenue Next Year
- AKTX N/A
- INKT N/A
- P/E Ratio
- AKTX N/A
- INKT N/A
- Revenue Growth
- AKTX N/A
- INKT N/A
- 52 Week Low
- AKTX $0.90
- INKT $0.46
- 52 Week High
- AKTX $4.40
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- AKTX 47.66
- INKT 56.81
- Support Level
- AKTX $1.13
- INKT $0.74
- Resistance Level
- AKTX $1.27
- INKT $0.91
- Average True Range (ATR)
- AKTX 0.13
- INKT 0.12
- MACD
- AKTX 0.03
- INKT 0.01
- Stochastic Oscillator
- AKTX 47.15
- INKT 45.48
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.